Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Oct;49(10):3000605211050539.
doi: 10.1177/03000605211050539.

Rare primary hepatic carcinosarcoma composed of hepatocellular carcinoma, cholangiocarcinoma, and sarcoma: a case report

Affiliations
Case Reports

Rare primary hepatic carcinosarcoma composed of hepatocellular carcinoma, cholangiocarcinoma, and sarcoma: a case report

Ze Liang et al. J Int Med Res. 2021 Oct.

Abstract

Primary hepatic carcinosarcoma (HCS) is an extremely rare malignant tumor of the liver that contains carcinomatous and sarcomatous components. The diagnosis, treatment, and prognosis of HCS pose great challenges to clinicians. Herein, we present a case of HCS in a 67-year-old man with unique pathological manifestation. Preoperative magnetic resonance imaging showed a malignant lesion in the right liver and a small sub-focus in the left liver. Radical treatment was performed, including excision of the right posterior lobe of the liver, thrombectomy of the right posterior portal vein, and radiofrequency ablation of lesions in the left liver. The specimens were confirmed to be HCS by pathological examinations, which revealed a combination of poorly differentiated hepatocellular carcinoma, moderately differentiated cholangiocellular carcinoma, and spindle cell sarcoma. Transhepatic arterial chemotherapy and embolization was performed after surgery. Unfortunately, pulmonary metastasis occurred 1.5 months later, which meant a poor prognosis. In this report, we discuss the clinicopathological characteristics of this case and factors that affected surgical outcomes, which may add some ideas for the future diagnosis and treatment of HCS patients.

Keywords: Liver; carcinosarcoma; case report; diagnosis; magnetic resonance imaging; tumor.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interest: The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
Computed tomography scans, non-enhanced and enhanced imaging. (a) Plain computed-tomography showed a heterogeneous hypoattenuating lesion in segments 7 and 8 of the liver; contrast-enhanced images showed a peripheral ring-like enhancement mass with reinforced septations. (b) Arterial; (c) portal; and (d) equilibrium phases of imaging.
Figure 2.
Figure 2.
Magnetic resonance imaging. (a) T1-weighted images; (b) T2-weighted images. After enhancement, the mass presented as an irregular ring-like enhancement. (c) Arterial phase, a sub-focus located in the lateral segment of the left liver (red arrow) was found. (d) Portal phase; (e) equilibrium phase; (f) embolus in branches of the right posterior portal vein (red arrow).
Figure 3.
Figure 3.
Pathological images. (a) Surgically resected specimen showing a multiple nodular-type mass with a central necrotic area. Hematoxylin–eosin (HE) staining (magnification: 100×) (b–c). (b) The poorly differentiated hepatocellular carcinoma (HCC; left), sarcomatous component (middle), and moderately differentiated cholangiocellular carcinoma (CCC; right). (c) There was a clear boundary between spindle and epithelial cells. Immunohistochemical staining (magnification: 40×) (d–g). (d) HepPar-1 was positive in the HCC component; (e–f) CK7 and CK19 were positive in the CCC component; (g) Vimentin was positive in the sarcomatous component.

References

    1. Nomura K Aizawa S andUshigome S.. Carcinosarcoma of the liver. Arch Pathol Lab Med. 2000; 124: 888–890. DOI: 10.5858/2000-124-0888-COTL - PubMed
    1. Gagnier JJ, Kienle G, Altman DG, et al.; CARE Group. The CARE guidelines: Consensus-based clinical case reporting guideline development. Headache. 2013; 53: 1541–1547. DOI: 10.1136/bcr-2013-201554 - PubMed
    1. Wang QB, Cui BK, Weng JM, et al.. Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma and carcinosarcoma of the liver. J Gastrointest Surg. 2012; 16: 1715–1726. DOI: 10.1007/s11605-012-1946-y - PubMed
    1. WHO Classification of Tumours Editorial Board. WHO Classification of Tumors: Digestive System Tumours. 5th ed. Lyon, France: International Agency for Research on Cancer; 2019.
    1. Bin F, Chen Z, Liu P, et al.. The clinicopathological and imaging characteristics of primary hepatic carcinosarcoma and a review of the literature. J Hepatocell Carcinoma. 2020; 7: 169–180. DOI: 10.2147/JHC.S272768 - PMC - PubMed

Publication types